USPTO serial 77227864
FUSOMAB
Reviewed by CopyMark Law Group
Reg. 4184636Status 710
- Filing date
- Status date
- Registration date
- Aug 7, 2012
- Examiner
- KING, LINDA M
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with FUSOMAB?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Mississauga, CA
MISSISSAUGA, ONTARIO, CA
MISSISSAUGA, ONTARIO, CA
MISSISSAUGA, ONTARIO, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
William F. Lawrence
WILLIAM F. LAWRENCE FROMMER LAWRENCE & HAUG LLP745 5TH AVENEW YORK, NY 10151-0099UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Biotechnology preparations for commercial purposes, namely, for use in the manufacture of biopharmaceutical and biotechnology products; diagnostic preparations for laboratory and/or medical research purposes; nucleic acids for laboratory use; biological tissue, namely, stem cells for scientific and medical research use; protein arrays for scientific and medical research; biochemicals, namely, monoclonal antibodies for in vitro scientific or research use | SECTION 8 - CANCELLED | — |
| 005 | Biopharmaceutical preparations and biotechnology preparations for medical purposes for the treatment of malignant and/or benign tumors; cancer; immune diseases, including autoimmune, inflammatory diseases, infectious diseases and vascular diseases; synthetic polypeptides for biopharmaceutical purposes; vaccines; diagnostic preparations for medical purposes; diagnostic preparations, namely, monoclonal antibodies, human antibodies, immune toxins; toxin proteins, and proteins for clinical or medical laboratory use | SECTION 8 - CANCELLED | — |
| 042 | Medical and scientific research and development services, namely, preparation and development of proteins and preparation and development services, namely, preparation and development of proteins and preparation and development of in vitro generated recombinant antibodies and proteins, and fragments thereof; product development services for others; preparation and screening of libraries of proteins and antibodies, libraries of cells producing antibodies and proteins, and libraries of vector coding for antibodies and proteins | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Viventia Biotech, Inc.
- Other trademarks owned by VIVENTIA BIOTECHNOLOGIES INC.
- Other trademarks owned by VIVENTIA BIOTECHNOLOGIES INC.
- Other trademarks owned by VIVENTIA BIOTECHNOLOGIES INC.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named FUSOMAB
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 8, 2019 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Aug 7, 2017 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Aug 7, 2012 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 22, 2012 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 22, 2012 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 2, 2012 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 16, 2012 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Apr 12, 2012 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 12, 2012 | DMCC | DATA MODIFICATION COMPLETED | — |
| Apr 11, 2012 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 11, 2012 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 11, 2012 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 11, 2012 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 4, 2012 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 3, 2012 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 3, 2012 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Mar 29, 2012 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Mar 29, 2012 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Mar 29, 2012 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Mar 9, 2012 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Aug 31, 2011 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Aug 23, 2011 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Feb 1, 2011 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Feb 1, 2011 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Feb 1, 2011 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jan 11, 2011 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 11, 2011 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 11, 2011 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Jul 15, 2010 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Jul 15, 2010 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Jul 15, 2010 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Jun 30, 2010 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Dec 30, 2009 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Dec 4, 2009 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Dec 4, 2009 | ALIE | ASSIGNED TO LIE | — |
| May 22, 2009 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| May 22, 2009 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| May 22, 2009 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Apr 27, 2009 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 27, 2009 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 24, 2009 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Oct 30, 2008 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Oct 30, 2008 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Oct 30, 2008 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Oct 21, 2008 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Oct 21, 2008 | ALIE | ASSIGNED TO LIE | — |
| Apr 21, 2008 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Apr 21, 2008 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Apr 21, 2008 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Mar 25, 2008 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 25, 2008 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 25, 2008 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 23, 2007 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 23, 2007 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 23, 2007 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 16, 2007 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 17, 2007 | NWAP | NEW APPLICATION ENTERED | — |